ROTAVAC 5D (live attenuated, oral rotavirus vaccine 116E)
/ Bharat Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 30, 2026
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
(clinicaltrials.gov)
- P3 | N=4270 | Completed | Sponsor: University of Chile | Recruiting ➔ Completed | Trial completion date: Jun 2025 ➔ Feb 2026 | Trial primary completion date: Jun 2025 ➔ Feb 2026
Trial completion • Trial completion date • Trial primary completion date • Gastroenterology • Gastrointestinal Disorder • Rotavirus Infections
May 22, 2025
Rota5DCHILE: The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
(clinicaltrials.gov)
- P3 | N=5800 | Active, not recruiting | Sponsor: Bharat Biotech International Limited | Recruiting ➔ Active, not recruiting | Trial completion date: Feb 2025 ➔ Jul 2026
Enrollment closed • Trial completion date • Infectious Disease • Rotavirus Infections
January 11, 2024
Rota5DCHILE: The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
(clinicaltrials.gov)
- P3 | N=5800 | Recruiting | Sponsor: Bharat Biotech International Limited
New P3 trial • Infectious Disease • Rotavirus Infections
1 to 3
Of
3
Go to page
1